A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models
about
sameAs
New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesotheliomaPotent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.The study on newly developed McAb NJ001 specific to non-small cell lung cancer and its biological characteristicsA novel rabbit immunospot array assay on a chip allows for the rapid generation of rabbit monoclonal antibodies with high affinityOverexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis.Functional Operons in Secondary Metabolic Gene Clusters in Glarea lozoyensis (Fungi, Ascomycota, Leotiomycetes)Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapyMonoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases.Discovering small molecule ligands of vascular endothelial growth factor that block VEGF-KDR binding using label-free microarray-based assays.Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues.Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism.Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.From rabbit antibody repertoires to rabbit monoclonal antibodiesPotential dual role of KGF/KGFR as a target option in novel therapeutic strategies for the treatment of cancers and mucosal damages.Antibody humanization methods - a review and update.A functional bioassay to determine the activity of anti-VEGF antibody therapy in blood of patients with cancer.Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumabHumanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples.Identification and in vitro characterization of phage-displayed VHHs targeting VEGF.Rabbit monoclonal antibody: potential application in cancer therapy.Isoform D of vascular endothelial growth factor in systemic capillary leak syndrome: a case report.Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production.Engineering humanized antibody framework sequences for optimal site-specific conjugation of cytotoxins.A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
P2860
Q28547381-B660CEEF-098A-434B-8AD4-B5FBB3AA52D0Q33858304-CA7E2115-FF46-4A65-8B17-452F7B6846F8Q34221272-EDD255F6-3CE0-43DE-934C-5E3EA68ED1B5Q34540651-88EA24AF-F641-4C48-87BB-A2F07B04A5AFQ34583152-6ACE445B-4E7F-444D-A221-4A52069F5A46Q35753679-3083E94C-34DA-4FB0-9843-F7460F0030BFQ36535215-0AE249F5-4582-4161-B022-7BF47F1343E3Q36821570-D0467C4F-4D3E-4E19-9E4B-4145167608A7Q36922576-DD53981E-42CF-4688-BBA4-65F96BA49983Q36936860-B4CDA20C-30DB-493C-BD4A-10B398E5B64DQ37031917-B6CAE4F8-57BD-4FAA-8549-09AE4482A7ACQ37260920-0F2E34D9-E5DD-44C5-8EE5-706DD78378EEQ37409489-9C79A6DB-9726-44F9-A015-295C68B49ABAQ37739483-3A9EFD63-FA72-4DAE-9702-18F17758A7F6Q37996468-6062AA3B-50F3-4C3B-B779-DF24959351A7Q38191015-77D1CD71-8DBC-4CCF-94AF-CB31FB435649Q38749030-2AA7937C-B796-4DB3-B218-594AF17A8033Q38823875-A88998BE-C35C-4A6B-9A44-3ACD46B598F7Q38976752-DA26407E-EEAE-405B-94FF-5A26CF68471DQ39051064-E3BF0503-5B6D-4616-85B1-58F98EB8A1DBQ41823846-75AAA894-0DBA-41AD-A11B-E4831095CBDAQ41890946-6997864B-50EB-4347-B45B-F504C36BBFD5Q47701879-B4DB5CBB-B060-4164-954C-474A721D0B38Q50637272-1D33E5B6-7457-4C60-9E5A-94D2BC197692Q58710181-56FF17CA-C595-4D1B-8AC4-25E95602FC04
P2860
A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@ast
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@en
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@nl
type
label
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@ast
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@en
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@nl
prefLabel
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@ast
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@en
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@nl
P2093
P2860
P3181
P1433
P1476
A humanized anti-VEGF rabbit m ...... mor growth in xenograft models
@en
P2093
Fernando Jose Rebelo Do Couto
Guo-Liang Yu
Jialiang Song
Jihong Dai
Jonathan Lee
Jungang Chen
Mingzhen Li
Pierre Lee
Weimin Zhu
P2860
P3181
P356
10.1371/JOURNAL.PONE.0009072
P407
P577
2010-02-05T00:00:00Z